{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:31:27Z","timestamp":1787031087131,"version":"build-2736575974"},"reference-count":0,"publisher":"OMICS Publishing Group","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["clinical-practice"],"DOI":"10.4172\/clinical-practice.1000125","type":"journal-article","created":{"date-parts":[[2017,11,29]],"date-time":"2017-11-29T07:24:38Z","timestamp":1511940278000},"source":"Crossref","is-referenced-by-count":14,"title":["Weight loss and diabetes are new risk factor for the development of invasive aspergillosis infection in non-immunocompromized humans"],"prefix":"10.4172","author":[{"given":"Farhad","family":"Ghanaat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A","family":"Tayek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2674","published-online":{"date-parts":[[2017]]},"container-title":["Clinical Practice"],"original-title":[],"deposited":{"date-parts":[[2017,11,29]],"date-time":"2017-11-29T07:24:39Z","timestamp":1511940279000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.openaccessjournals.com\/articles\/weight-loss-and-diabetes-are-new-risk-factor-for-the-development-of-invasive-aspergillosis-infection-in-nonimmunocompromizedhumans-12172.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":0,"URL":"https:\/\/doi.org\/10.4172\/clinical-practice.1000125","relation":{},"ISSN":["2044-9038"],"issn-type":[{"value":"2044-9038","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}